Medicine and Dentistry
Patient
100%
Inpatient
42%
Brain Natriuretic Peptide
32%
Atrial Fibrillation
32%
Therapeutic Procedure
29%
Heart Failure
25%
Acute Heart Infarction
24%
Follow up
24%
Predictor
21%
Metabolic Syndrome
20%
Percutaneous Coronary Intervention
16%
Myocardial Infarction
15%
Vitamin K Antagonist
15%
Stent
14%
Primary Percutaneous Coronary Intervention
14%
Systolic Blood Pressure
14%
Platelet Reactivity
14%
Clopidogrel
14%
Drug-Eluting Stent
14%
Intravascular Ultrasound
13%
Obesity
13%
Cardiovascular System
13%
Hazard Ratio
12%
Diabetes Mellitus
12%
Stent Thrombosis
11%
ST Segment Elevation Myocardial Infarction
10%
Obstruction
10%
Odds Ratio
10%
All Cause Mortality
10%
Systolic Heart Failure
9%
Mortality
9%
Male
9%
Left Ventricle
9%
Age
9%
Body Mass Index
9%
Lesion
9%
Combination Therapy
9%
Coronary Angiography
9%
Radial Artery
8%
Major Adverse Cardiac Event
8%
Prasugrel
8%
Ejection Fraction
8%
Man
8%
Cardiovascular Disease
7%
Protocol Compliance
7%
Association
7%
Gender
7%
Heart Death
7%
In-Stent Restenosis
6%
Cilostazol
6%
Nursing and Health Professions
Patient
31%
Brain Natriuretic Peptide
18%
Atrial Fibrillation
14%
Follow up
13%
Antivitamin K
12%
Inpatient
11%
Heart Failure
10%
Clopidogrel
9%
Systolic Blood Pressure
7%
Cilostazol
6%
Losartan
6%
Procedures
6%
Acute Heart Infarction
6%
International Normalized Ratio
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antivitamin K
14%
Stent
13%
Atrial Fibrillation
12%
Clopidogrel
9%
Losartan
8%
Heart Failure
8%
Anticoagulant Agent
7%
Amlodipine
6%
Cilostazol
6%
Adiponectin
6%
Metabolic Syndrome X
6%
Congestive Cardiomyopathy
6%
Obesity
6%
Gamma Interferon
6%
Isoprenaline
6%
Systolic Heart Failure
5%
